Both in Pharmaceuticals
Artelo Biosciences vs Karyopharm Therapeutics
Over the past year ARTL returned −95.5% and KPTI returned −98.7%; their daily moves had a correlation of -0.01.
ARTL −95.5% KPTI −98.7%Growth of $1, one year, split-adjusted
| Metric | ARTL | KPTI |
|---|---|---|
| Price | $2.27 | $0.0729 |
| Market cap | $1.2M | $1.7M |
| Today | −5.42% | −17.44% |
| 1 month | −34.4% | −88.8% |
| 6 months | −90.9% | −99.2% |
| Year to date | −93.1% | −99.0% |
| 1 year | −97.2% | −98.8% |
| Revenue growth (YoY) | — | −11.9% |
| Gross margin | — | 96.8% |
| Net margin | — | −200.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.0× |
| Net cash | $4.2M | -$184.8M |
| Dividend yield | — | — |
| Volatility (60d) | 650.5% | 413.8% |
| Short % of float | 0.8% | 34.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).